Jones Trading Initiates Coverage On Editas Medicine with Buy Rating, Announces Price Target of $13
Portfolio Pulse from Benzinga Newsdesk
Jones Trading has initiated coverage on Editas Medicine with a Buy rating and set a price target of $13.
September 17, 2024 | 8:43 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jones Trading has initiated coverage on Editas Medicine with a Buy rating and a price target of $13, indicating a positive outlook for the stock.
The initiation of coverage with a Buy rating and a specific price target of $13 by Jones Trading suggests a positive sentiment towards Editas Medicine. This is likely to influence investor perception and could lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100